Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Genetic variation determines VEGF-A plasma levels in cancer patients.
GH response to intravenous clonidine challenge: absence of relationship with behavioral irritability, aggression, or impulsivity in human subjects.
Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Genetic variation determines VEGF-A plasma levels in cancer patients.
Genetic variation determines VEGF-A plasma levels in cancer patients. Sci Rep. 2018 11 05; 8(1):16332.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Colorectal Neoplasms
Female
Humans
Male
Middle Aged
Neovascularization, Pathologic
NFATC Transcription Factors
Polymorphism, Single Nucleotide
RNA, Messenger
Vascular Endothelial Growth Factor A
Young Adult
authors with profiles
Mark J. Ratain
Hedy Kindler